- •Экзаменационная аннотация на лекарственный препарат для перевода без словаря по дисциплине «Английский язык»
- •Экзаменационная аннотация на лекарственный препарат для перевода без словаря по дисциплине «Английский язык»
- •Экзаменационная аннотация на лекарственный препарат для перевода без словаря по дисциплине «Английский язык»
- •Экзаменационная аннотация на лекарственный препарат для перевода без словаря по дисциплине «Английский язык»
- •Экзаменационная аннотация на лекарственный препарат для перевода без словаря по дисциплине «Английский язык»
- •Экзаменационная аннотация на лекарственный препарат для перевода без словаря по дисциплине «Английский язык»
№ 1
Экзаменационная аннотация на лекарственный препарат для перевода без словаря по дисциплине «Английский язык»
(итоговый контроль 2 курс)
IMUDON
Trade name: IMUDON
Dosage form: sucking tablets.
Composition
The drug is a polyvalent antigenic complex, a mixture of bacterial lysates, whose composition corresponds to that of the pathogens that more often cause inflammatory processes in the oral cavity and throat.
Description
White or almost white planocylindrical tablets with a smooth luster surface, without pores.
Pharmacotherapeutical group Immunostimulant.
Pharmacological properties A bacterial immunostimulant for local use in dentistry and otolaryngology.
Activates phagocytosis, promotes the increase in the count of immunocompetent cells, enhances the production of lysozyme and interferon, salivary secretary immunoglobulin A.
Indications
Treatment and (or) prevention of inflammatory and infectious oral and pharyngeal diseases:
•pharyngitis;
•chronic tonsillitis;
•oral dysbacteriosis;
•erythematous and ulcerative gingivitis;
•ulcerations caused by dentures.
Contraindications
•individual hypersensitivity to the active ingredient or
any other components of the product;
•children under 3 years of age.
Pregnancy and lactation
Information on the use of Imudon in pregnant females is insufficient . There are no relevant data of animal experiments and epidemiological studies. The use of Imudon is not recommended during pregnancy and lactation.
Dosage and administration
For adults and adolescents above 14 years In acute and inflammatory diseases of the oral cavity and throat and exacerbations of chronic diseases the drug should be used as 8 tablets daily. The tablets should be sucked (without chewing) in the oral cavity at an interval of 1 hour. The mean duration of a therapy course is 10 days.
For the prevention of chronic inflammatory diseases of the oral cavity and throat, the drug should be used as 6 tablets daily. The tablets should be sucked (without chewing) in the oral cavity at an interval of 2 hours. The duration of a course is 20 days. Three-four annual courses of preventive Imudon therapy are recommended.
For children aged 3 to 14 years
For the treatment of acute and recurrent chronic inflammatory diseases of the oral cavity and throat and for their prevention, the drug should be used as 6 tablets daily. The tablets should be sucked (without chewing) in the oral cavity at an interval of 2 hours. The duration of a therapy course for acute diseases is 10 days, that for the prevention of chronic diseases is 20 days.
Three-four annual courses of preventive therapy with the drug are recommended.
Adverse reactions
In rare cases the use of the drug may cause allergic reactions (eruption, urticaria, angioneurotic edema). There may be gastrointestinal reactions (nausea, vomiting, abdominal pain).
Overdosage
Cases of IMUDON overdosage have not been described.
Drug interactions
IMUDON may be used in combination with drugs from other groups.
Special instructions
Children aged 3 to 6 years are to suck the tablets in the oral cavity under adult control!
If required, the mouth should be gargled not earlier than 1 hour after the use of IMUDON not to reduce the therapeutic activity of the drug.
When the drug is prescribed to patients on a salt-free or restricted diet, it should be taken into account that 1 tablet of IMUDON contains 15 mg of sodium.
Effect on the capacity of driving a car and handling with other mechanisms
There are no data suggesting that the activities associated with the driving of a car or handling with other mechanisms should be limited during treatment.
Pack
A blister contains 8 tablets. A cardboard pack contains 5 blisters.
Storage
The drug should be stored at a temperature of not above 25 C. To keep out of the reach of children!
Denture dentures– вставные челюсти
|
№ 2